Bridget Mehall
YOU?
Author Swipe
View article: Dual Axl/<scp>MerTK</scp> inhibitor <scp>INCB081776</scp> creates a proinflammatory tumor immune microenvironment and enhances <scp>anti‐PDL1</scp> efficacy in head and neck cancer
Dual Axl/<span>MerTK</span> inhibitor <span>INCB081776</span> creates a proinflammatory tumor immune microenvironment and enhances <span>anti‐PDL1</span> efficacy in head and neck cancer Open
Background The tyrosine kinase receptors Axl and MerTK are highly overexpressed in head and neck cancer (HNC) cells, where they are critical drivers of survival, proliferation, metastasis, and therapeutic resistance. Methods We investigate…